Age-standardized rates of PUD globally and for 21 GBD regions by SDI, 1990–2021. حسب Wende Hao (10315597)

الموضوعات:

The top four countries or territories with the lowest ASRs of PUD in 2021. حسب Wende Hao (10315597)

الموضوعات:

Trends in the all-age numbers and age-standardized incidence, prevalence, mortality and DALYs rates of PUD by sex from 1990 to 2021. حسب Wende Hao (10315597)

الموضوعات:

Numbers and age-standardized incidence, prevalence, deaths and DALYs rates of peptic ulcer disease in 2021. حسب Wende Hao (10315597)

الموضوعات:

Proportion of PUD DALYs and deaths attributable to smoking by gender, SDI quintile, and GBD region in 1990 and 2021. حسب Wende Hao (10315597)

الموضوعات:

S1 File - Global burden and risk factors of peptic ulcer disease between 1990 and 2021: An analysis from the global burden of disease study 2021 حسب Wende Hao (10315597)

الموضوعات:

Numbers and age-standardized incidence, prevalence, deaths and DALYs rates of peptic ulcer disease in 1990. حسب Wende Hao (10315597)

الموضوعات:

The top four countries or territories with the highest ASRs of PUD in 2021. حسب Wende Hao (10315597)

الموضوعات:

Joinpoint regression analysis of the sex-specific ASRs for PUD globally from 1990 to 2021. حسب Wende Hao (10315597)

الموضوعات:

Predicted trends in Age-standardized rates of PUD for both sexes globally over the next 19 years (2022-2040). حسب Wende Hao (10315597)

الموضوعات:

Age-specific numbers and rates of PUD globally in 2021 for both sexes. حسب Wende Hao (10315597)

الموضوعات:

Host population bottlenecks decrease microbiome diversity. حسب Michael Ørsted (5926028)

Diagram of displacement variation. حسب Yifei Li (198040)

Significantly decreased necrosis observed on wheat leaves inoculated with <i>ΔZtknr4</i>. حسب Erika Kroll (20537020)

Temperature challenge protocol. حسب Kevin D. Gaitonde (15411707)

الموضوعات:

The 587 genes with a significant variation following Tan treatment in TE-1 cells. حسب Dong Yang (141041)

Predicted behavioural expression of young (orange) and old (blue) individuals that do (treatment) or do not (control) receive an immune challenge. حسب Antoine Bour (20489426)

"…If an immune-challenged individual’s sickness remains stable (i.e. there is no recovery or increased illness) between behavioural tests then we do not expect to find significant within-individual variation within either age category. …"

Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s. حسب Djaloul Karboua (16510091)

Interannual variation rate, coefficient of variation and change trend of NDVI. حسب Wang Runke (13256851)

الموضوعات:

Metformin/rifampicin combination decreases <i>S</i>. <i>aureus</i> load and persisters in Mice. حسب Xiao-Qi Lin (9548375)